HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging

PURPOSE: The aim of the present paper is to review the role of HER2 antibodies, affibodies and nanobodies as vehicles for imaging and therapy approaches in breast cancer, including a detailed look at recent clinical data from antibody drug conjugates and nanobodies as well as affibodies that are cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Altunay, Betül, Morgenroth, Agnieszka, Beheshti, Mohsen, Vogg, Andreas, Wong, Nicholas C. L., Ting, Hong Hoi, Biersack, Hans-Jürgen, Stickeler, Elmar, Mottaghy, Felix M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113197/
https://www.ncbi.nlm.nih.gov/pubmed/33179151
http://dx.doi.org/10.1007/s00259-020-05094-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113197/
https://www.ncbi.nlm.nih.gov/pubmed/33179151
http://dx.doi.org/10.1007/s00259-020-05094-1

Ejemplares similares